1. Home
  2. DTSS vs QNRX Comparison

DTSS vs QNRX Comparison

Compare DTSS & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.84

Market Cap

9.0M

Sector

Technology

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$5.91

Market Cap

10.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTSS
QNRX
Founded
2014
2018
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0M
10.7M
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
DTSS
QNRX
Price
$0.84
$5.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
87.6K
20.8K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$71,616,820.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
198.70
N/A
52 Week Low
$0.64
$5.20
52 Week High
$2.60
$41.80

Technical Indicators

Market Signals
Indicator
DTSS
QNRX
Relative Strength Index (RSI) 41.12 43.31
Support Level $0.81 $5.34
Resistance Level $1.01 $6.98
Average True Range (ATR) 0.07 0.47
MACD -0.02 0.06
Stochastic Oscillator 13.83 47.65

Price Performance

Historical Comparison
DTSS
QNRX

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: